Compare CVGI & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVGI | HYFT |
|---|---|---|
| Founded | 2000 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.5M | 69.6M |
| IPO Year | 2004 | N/A |
| Metric | CVGI | HYFT |
|---|---|---|
| Price | $1.51 | $1.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 128.5K | ★ 316.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 316.18 | N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $755,231,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $51.71 |
| P/E Ratio | $39.50 | ★ N/A |
| Revenue Growth | ★ 14.06 | N/A |
| 52 Week Low | $0.81 | $1.05 |
| 52 Week High | $2.10 | $3.00 |
| Indicator | CVGI | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 41.42 | 32.88 |
| Support Level | $1.46 | N/A |
| Resistance Level | $1.85 | $2.17 |
| Average True Range (ATR) | 0.11 | 0.09 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 15.79 | 16.28 |
Commercial Vehicle Group Inc is a provider of systems, assemblies, and components to the commercial vehicle market and the electric vehicle markets. It delivers solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities. Its operating segments are Vehicle Solutions, Electrical Systems, and Aftermarket and Accessories. The company makes the majority of its revenue from Vehicle Solutions. The group generates revenue from its products including seating systems, plastic components, electrical wire harnesses, mirrors, wipers, and other accessories. Its geographic regions are North America, Europe and Asia-Pacific.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.